-DOCSTART- -X- O
N -X- _ B-Intervention
( -X- _ I-Intervention
4 -X- _ I-Intervention
) -X- _ I-Intervention
-Hydroxycytidine -X- _ I-Intervention
( -X- _ I-Intervention
NHC -X- _ I-Intervention
) -X- _ I-Intervention
is -X- _ O
an -X- _ O
antiviral -X- _ O
ribonucleoside -X- _ O
analog -X- _ O
that -X- _ O
acts -X- _ O
as -X- _ O
a -X- _ O
competitive -X- _ O
alternative -X- _ O
substrate -X- _ O
for -X- _ O
virally -X- _ O
encoded -X- _ O
RNA-dependent -X- _ O
RNA -X- _ O
polymerases. -X- _ O
It -X- _ O
exhibits -X- _ O
measurable -X- _ O
levels -X- _ O
of -X- _ O
cytotoxicity -X- _ O
, -X- _ O
with -X- _ O
50 -X- _ B-Intervention
% -X- _ I-Intervention
cytotoxic -X- _ I-Intervention
concentration -X- _ I-Intervention
values -X- _ I-Intervention
ranging -X- _ I-Intervention
from -X- _ I-Intervention
7.5 -X- _ I-Intervention
μM -X- _ I-Intervention
in -X- _ I-Intervention
CEM -X- _ I-Intervention
cells -X- _ I-Intervention
and -X- _ I-Intervention
up -X- _ I-Intervention
to -X- _ I-Intervention
> -X- _ I-Intervention
100 -X- _ I-Intervention
μM -X- _ I-Intervention
in -X- _ I-Intervention
other -X- _ I-Intervention
cell -X- _ I-Intervention
lines. -X- _ I-Intervention
The -X- _ O
mitochondrial -X- _ O
DNA-dependent -X- _ O
RNA -X- _ O
polymerase -X- _ O
( -X- _ O
POLRMT -X- _ O
) -X- _ O
has -X- _ O
been -X- _ O
shown -X- _ O
to -X- _ O
incorporate -X- _ O
some -X- _ O
nucleotide -X- _ O
analogs -X- _ O
into -X- _ O
mitochondrial -X- _ O
RNAs -X- _ O
, -X- _ O
resulting -X- _ O
in -X- _ O
substantial -X- _ O
mitochondrial -X- _ O
toxicity. -X- _ O
NHC -X- _ B-Intervention
was -X- _ O
tested -X- _ O
in -X- _ O
multiple -X- _ O
assays -X- _ O
intended -X- _ O
to -X- _ O
determine -X- _ O
its -X- _ O
potential -X- _ O
to -X- _ O
cause -X- _ O
mitochondrial -X- _ O
toxicity. -X- _ O
NHC -X- _ B-Intervention
showed -X- _ O
similar -X- _ O
cytotoxicity -X- _ O
in -X- _ O
HepG2 -X- _ B-Patient
cells -X- _ I-Patient
incubated -X- _ O
in -X- _ O
a -X- _ O
glucose-free -X- _ O
and -X- _ O
glucose-containing -X- _ O
media -X- _ O
, -X- _ O
suggesting -X- _ O
that -X- _ O
NHC -X- _ B-Intervention
does -X- _ O
not -X- _ O
impair -X- _ O
mitochondrial -X- _ O
function -X- _ O
in -X- _ O
this -X- _ O
cell -X- _ O
line -X- _ O
based -X- _ O
on -X- _ O
the -X- _ O
Crabtree -X- _ O
effect. -X- _ O
We -X- _ O
demonstrate -X- _ O
that -X- _ O
the -X- _ O
5′-triphosphate -X- _ O
of -X- _ O
NHC -X- _ B-Intervention
can -X- _ O
be -X- _ O
used -X- _ O
by -X- _ O
POLRMT -X- _ O
for -X- _ O
incorporation -X- _ O
into -X- _ O
nascent -X- _ O
RNA -X- _ O
chain -X- _ O
but -X- _ O
does -X- _ O
not -X- _ O
cause -X- _ O
immediate -X- _ O
chain -X- _ O
termination. -X- _ O
In -X- _ O
PC-3 -X- _ B-Patient
cells -X- _ I-Patient
treated -X- _ O
with -X- _ O
NHC -X- _ B-Intervention
, -X- _ O
the -X- _ O
50 -X- _ O
% -X- _ O
inhibitory -X- _ O
concentrations -X- _ O
of -X- _ O
mitochondrial -X- _ O
protein -X- _ O
expression -X- _ O
inhibition -X- _ O
were -X- _ O
2.7-fold -X- _ O
lower -X- _ O
than -X- _ O
those -X- _ O
for -X- _ O
nuclear-encoded -X- _ O
protein -X- _ O
expression -X- _ O
, -X- _ O
but -X- _ O
this -X- _ O
effect -X- _ O
did -X- _ O
not -X- _ O
result -X- _ O
in -X- _ O
selective -X- _ O
mitochondrial -X- _ O
toxicity. -X- _ O
A -X- _ O
14-day -X- _ O
incubation -X- _ O
of -X- _ O
HepG2 -X- _ B-Patient
cells -X- _ I-Patient
with -X- _ O
NHC -X- _ B-Intervention
had -X- _ O
no -X- _ O
effect -X- _ O
on -X- _ O
mitochondrial -X- _ O
DNA -X- _ O
copy -X- _ O
number -X- _ O
or -X- _ O
extracellular -X- _ O
lactate -X- _ O
levels. -X- _ O
In -X- _ O
CEM -X- _ B-Patient
cells -X- _ I-Patient
treated -X- _ O
with -X- _ O
NHC -X- _ B-Intervention
at -X- _ O
10 -X- _ O
μM -X- _ O
, -X- _ O
a -X- _ O
slight -X- _ O
decrease -X- _ O
( -X- _ O
by -X- _ O
∼20 -X- _ O
% -X- _ O
) -X- _ O
in -X- _ O
mitochondrial -X- _ O
DNA -X- _ O
copy -X- _ O
number -X- _ O
and -X- _ O
a -X- _ O
corresponding -X- _ O
slight -X- _ O
increase -X- _ O
in -X- _ O
extracellular -X- _ O
lactate -X- _ O
levels -X- _ O
were -X- _ O
detected -X- _ O
, -X- _ O
but -X- _ O
these -X- _ O
effects -X- _ O
were -X- _ O
not -X- _ O
enhanced -X- _ O
by -X- _ O
an -X- _ O
increase -X- _ O
in -X- _ O
NHC -X- _ B-Intervention
treatment -X- _ O
concentration. -X- _ O
In -X- _ O
summary -X- _ O
, -X- _ O
the -X- _ O
results -X- _ O
indicate -X- _ O
that -X- _ O
mitochondrial -X- _ B-Outcome
impairment -X- _ I-Outcome
by -X- _ I-Outcome
NHC -X- _ I-Outcome
is -X- _ I-Outcome
not -X- _ I-Outcome
the -X- _ I-Outcome
main -X- _ I-Outcome
contributor -X- _ I-Outcome
to -X- _ I-Outcome
the -X- _ I-Outcome
compound’s -X- _ I-Outcome
observed -X- _ I-Outcome
cytotoxicity -X- _ I-Outcome
in -X- _ I-Outcome
these -X- _ I-Outcome
cell -X- _ I-Outcome
lines -X- _ I-Outcome
. -X- _ O

